Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

TLC SP, ?3.75mm RT, SLActive? 8mm RXD: medical device reports filed with FDA

308 reports name it, 2024–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

308
device reports naming the brand
0% of all MAUDE reports · about 128 a year
193
reports, 12 months to August 2026
101 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

308 medical device reports received by FDA name the brand "TLC SP, ?3.75mm RT, SLActive? 8mm RXD" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from February 2024 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

193 reports arrived in the 12 months to August 2026, up 91% from 101 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (78.9%), loss of osseointegration (13.3%) and difficult to insert (1.3%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01734Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 0Apr 2022: 0May 2022: 0Jun 2022: 0Jul 2022: 0Aug 2022: 0Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 0Aug 2023: 0Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 02024Jan 2024: 0Feb 2024: 2Mar 2024: 1Apr 2024: 0May 2024: 2Jun 2024: 1Jul 2024: 3Aug 2024: 5Sep 2024: 2Oct 2024: 9Nov 2024: 6Dec 2024: 42025Jan 2025: 4Feb 2025: 2Mar 2025: 3Apr 2025: 10May 2025: 0Jun 2025: 34Jul 2025: 15Aug 2025: 12Sep 2025: 7Oct 2025: 22Nov 2025: 8Dec 2025: 102026Jan 2026: 11Feb 2026: 12Mar 2026: 24Apr 2026: 21May 2026: 19Jun 2026: 14Jul 2026: 26Aug 2026: 19

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0731462024: 3520242025: 12720252026: 1462026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%308
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report93.5%288
Voluntary report0%0
User facility report0%0
Distributor report6.5%20
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate24378.9%62.8%
Loss of osseointegration4113.3%22.4%
Difficult to insertthe device was hard to insert41.3%0.4%
Separation failure20.6%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis9631.2%
Painpain, site not specified5618.2%
Inflammationinflammation185.8%
Hemorrhage/blood loss/bleeding134.2%
Swelling/ edema103.2%
Hyperresponsive to stimuli92.9%
Abscessa collection of pus31%
Fistula31%
Sinus perforation20.6%
Hypersensitivity/allergic reaction10.3%
Numbnessnumbness10.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureTLC SP, ?3.75mm RT, SLActive? 8mm RXDProduct code DZEAll MAUDE reports
Reports3083,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer93.5%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about TLC SP, ?3.75mm RT, SLActive? 8mm RXD reports

How many FDA reports name TLC SP, ?3.75mm RT, SLActive? 8mm RXD?

308 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 193 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (78.9%), loss of osseointegration (13.3%), difficult to insert (1.3%) and separation failure (0.6%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (93.5%) and distributor reports (6.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that TLC SP, ?3.75mm RT, SLActive? 8mm RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.